Tanvex BioPharma
6541.TW
1.25 USD
-0.02
-1.57%
t
Overview
Last close
1.25 usd
Market cap
332.17M usd
52 week high
2.50 usd
52 week low
1.24 usd
Target price
1.67 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
26.2571
Price/Book Value
1.8258
Enterprise Value
354.04M usd
EV/Revenue
27.6718
EV/EBITDA
-9.0582
Key financials
Revenue TTM
12.79M usd
Gross Profit TTM
-14.06M usd
EBITDA TTM
-39.74M usd
Earnings per Share
-0.2 usd
Dividend
N/A usd
Total assets
253.63M usd
Net debt
22.29M usd
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
- Symbol6541.TW
- ExchangeTW
- IsinKYG8676P1037
- CountryCayman Islands
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterGeorge Town
- Web sitehttps://www.tanvex.com
